Paul A. Jones - 07 Feb 2022 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
Chief Leadership Dev Officer
Signature
Josh Foukas, as attorney in fact.
Issuer symbol
USNA
Transactions as of
07 Feb 2022
Net transactions value
-$44,510
Form type
4
Filing time
10 Feb 2022, 14:02:34 UTC
Previous filing
08 Feb 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +1,457 +19% 9,183 08 Feb 2022 Direct F1
transaction USNA Common Stock Tax liability $44,510 -472 -5.1% $94.30 8,711 08 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock units Award $0 +5,490 +63% $0.000000 14,235 07 Feb 2022 Common Stock 5,490 Direct F1, F3
transaction USNA Restricted Stock Units Options Exercise $0 -1,457 -10% $0.000000 12,778 08 Feb 2022 Common Stock 1,457 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 Restricted Stock Units vest 25% on the anniversary of February 8th, 2021.
F3 On February 7th, 2022, the reporting person was granted restricted stock units, vesting at 25% on each 7th of February thereafter.